Brian Goff Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian Goff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian Goff. Brian Goff is a EVP & Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP and President, Hematology in Baxalta Inc ($BXLT).
Address: C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE 02139 MA
Companies in which Brian Goff is an Insider
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian Goff: EVP & Chief Commercial Officer
Holdings: 88,696 shares
Current Value: $11,328,253
Latest Transaction: Dec 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Baxalta Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian Goff: EVP and President, Hematology
Holdings: 0 shares
Latest Transaction: Jun 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Brian Goff
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 3,261 | 515,108 | 67,301 | 70.6 K to 67.3 K (-4.62 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 18,134 | 2,864,447 | 70,562 | 88.7 K to 70.6 K (-20.45 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 40,677 | 0 | 88,696 | 48 K to 88.7 K (+84.71 %) |
| Jun 09 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 114.61 | 1,642 | 188,190 | 48,019 | 49.7 K to 48 K (-3.31 %) |
| Feb 10 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 102.97 | 1,594 | 164,134 | 40,182 | 41.8 K to 40.2 K (-3.82 %) |
| Jun 11 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 118.61 | 1,643 | 194,876 | 41,776 | 43.4 K to 41.8 K (-3.78 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 9,428 | 0 | 43,419 | 34 K to 43.4 K (+27.74 %) |